
KSQ-4279
CAS No. 2446480-97-1
KSQ-4279( —— )
Catalog No. M35309 CAS No. 2446480-97-1
KSQ-4279 (USP1-IN-1) is an inhibitor of USP1 and PARP, exhibiting anticancer activity. It is utilized in the study of non-small cell lung cancer, osteosarcoma, ovarian, breast, glioblastoma, bladder, uterine, and pancreatic cancers.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 240 | Get Quote |
![]() ![]() |
5MG | 376 | Get Quote |
![]() ![]() |
10MG | 560 | Get Quote |
![]() ![]() |
25MG | 868 | Get Quote |
![]() ![]() |
50MG | 1178 | Get Quote |
![]() ![]() |
100MG | 1548 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameKSQ-4279
-
NoteResearch use only, not for human use.
-
Brief DescriptionKSQ-4279 (USP1-IN-1) is an inhibitor of USP1 and PARP, exhibiting anticancer activity. It is utilized in the study of non-small cell lung cancer, osteosarcoma, ovarian, breast, glioblastoma, bladder, uterine, and pancreatic cancers.
-
DescriptionKSQ-4279 (USP1-IN-1) is a potent, first-in-class, and highly selective USP1 inhibitor. KSQ-4279 shows anticancer effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP | DUB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2446480-97-1
-
Formula Weight534.54
-
Molecular FormulaC27H25F3N8O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 80 mg/mL (149.66 mM; Ultrasonic )
-
SMILESCOc1ncnc(C2CC2)c1-c1ncc2cnn(Cc3ccc(cc3)-c3nc(cn3C(C)C)C(F)(F)F)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Natalie Y L Ngoi, et al. Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations. Curr Opin Oncol. 2022 Sep 1;34(5):559-569.?
molnova catalog



related products
-
Rucaparib phosphate
An inhibitor of PARP with Ki of 1.4 nM for PARP1 in a cell-free assay.
-
Venadaparib
Venadaparib (IDX-1197) is a potent, selective and orally active PARP inhibitor with IC50s of 1.4 nM and 1.0 nM for PARP1 and PARP2, respectively.
-
RBN012759
RBN012759, a potent and selective PARP14 inhibitor, decreases pro-tumor macrophage function and elicits inflammatory responses in tumor explants.